Molecular medicine in lung cancer

Current and future immune approaches in precision medicine

Incorporating liquid biopsies into clinical trials

Bayesian adaptive trial designs for precision medicine

Redesigning clinical trials in the era of precision medicine

Genomic-driven clinical studies in breast cancer

Synthetic lethality as a basis to select drug combinations

Patient-specific peptide vaccines

Novel models to personalise cancer therapeutics

Impact of mutational profile at diagnosis for MDS/CML

Disruption of BAFF-BCR crosstalk in CLL

European guidelines for breast cancer treatment